Dose reduction of biological treatment in patients with axial spondyloarthritis in clinical remission: Are there any differences between patients who relapsed and to those who remained in low disease activity?
Crossref DOI link: https://doi.org/10.1007/s00296-015-3288-z
Published Online: 2015-05-21
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Almirall, Miriam
Salman-Monte, Tarek Carlos
Lisbona, Maria Pilar
Maymó, Joan
Text and Data Mining valid from 2015-05-21